Published in Am J Infect Dis on January 01, 2006
The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer. J Clin Endocrinol Metab (2001) 2.61
Effects of major depression on remission and relapse of substance dependence. Arch Gen Psychiatry (2002) 2.56
Interaction between glucocorticoid hormones, stress and psychostimulant drugs. Eur J Neurosci (2002) 2.16
The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution. J Clin Endocrinol Metab (1993) 1.94
The role of corticotropin-releasing factor and corticosterone in stress- and cocaine-induced relapse to cocaine seeking in rats. J Neurosci (1998) 1.91
Corticotropin-releasing factor, but not corticosterone, is involved in stress-induced relapse to heroin-seeking in rats. J Neurosci (1997) 1.84
Screening for depressive symptoms among HCV-infected injection drug users: examination of the utility of the CES-D and the Beck Depression Inventory. J Urban Health (2004) 1.62
Neuroendocrine aspects of hypercortisolism in major depression. Horm Behav (2003) 1.60
Testosterone replacement therapy improves mood in hypogonadal men--a clinical research center study. J Clin Endocrinol Metab (1996) 1.57
Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal. Behav Pharmacol (1995) 1.36
Opiate use and sexual function. Am J Psychiatry (1980) 1.20
A long-term, prospective study of the physiologic and behavioral effects of hormone replacement in untreated hypogonadal men. J Androl (1992) 1.17
Cocaine's effects on neuroendocrine systems: clinical and preclinical studies. Pharmacol Biochem Behav (1997) 1.13
Effect of gonadectomy and gonadal hormone replacement on cocaine self-administration in female and male rats. Neuropsychopharmacology (2004) 1.11
Opioid-induced suppression of rat testicular function. J Pharmacol Exp Ther (1993) 1.03
Effects of testosterone administration on fat distribution, insulin sensitivity, and atherosclerosis progression. Clin Infect Dis (2003) 0.95
Testosterone as well as estrogen increases serotonin2A receptor mRNA and binding site densities in the male rat brain. Brain Res Mol Brain Res (1998) 0.95
Opiate drug use: a potential contributor to the endocrine and metabolic complications in human immunodeficiency virus disease. Clin Infect Dis (2003) 0.95
Treatment-seeking inpatient cocaine abusers show hypothalamic dysregulation of both basal prolactin and cortisol secretion. Neuroendocrinology (2003) 0.94
Metyrapone-induced withdrawal symptoms. Br J Addict (1990) 0.93
Ketoconazole reduces low dose cocaine self-administration in rats. Drug Alcohol Depend (1998) 0.93
Psychiatric comorbidity and suicidality among intravenous drug users. J Clin Psychiatry (1992) 0.92
Impaired circadian rhythmicity of beta-lipotrophin, beta-endorphin and ACTH in heroin addicts. Acta Endocrinol (Copenh) (1984) 0.91
Effects of heroin and methadone on plasma cortisol and testosterone. J Pharmacol Exp Ther (1975) 0.91
Neuroendocrine-related effects of long-term, 'binge' cocaine administration: diminished individual differences in stress-induced corticosterone response. Neuroendocrinology (1998) 0.90
Effects of cocaine on cortisol secretion in humans. Am J Med Sci (1995) 0.85
Hypercortisolism after opioid discontinuation in rapid detoxification of heroin addicts. Br J Addict (1992) 0.85
Effects of self-administered cocaine on plasma adrenocorticotropic hormone and cortisol in male rhesus monkeys. J Pharmacol Exp Ther (1999) 0.84
Testosterone regulates pro-opiomelanocortin gene expression in the primate brain. Endocrinology (1991) 0.84
The role of exogenous testosterone in cocaine-induced behavioral sensitization and plasmalemmal or vesicular dopamine uptake in castrated rats. Neurosci Lett (2003) 0.84
Loperamide inhibits corticotrophic cell function by a naloxone-insensitive mechanism in the rat in vitro. Neuroendocrinology (1993) 0.84
Heroin and naltrexone effects on pituitary-gonadal hormones in man: interaction of steroid feedback effects, tolerance and supersensitivity. J Pharmacol Exp Ther (1980) 0.83
Ketoconazole attenuates the cortisol response but not the subjective effects of smoked cocaine in humans. Behav Pharmacol (1998) 0.83
Abnormal adrenal gland metabolism in opioid addicts: implications for clinical treatment. J Psychoactive Drugs (1992) 0.82
Testosterone implantation reduces the motor effects of cocaine. Behav Pharmacol (1994) 0.81
Semen evaluation in heroin and methadone addicts. Acta Eur Fertil (1985) 0.80
The effect of heroin addiction on pituitary-testicular function. Clin Endocrinol (Oxf) (1978) 0.80
Effects of cocaine on luteinizing hormone in women during the follicular and luteal phases of the menstrual cycle and in men. J Pharmacol Exp Ther (2001) 0.80
Further studies on the effects of heroin addiction on the hypothalamic-pituitary-gonadal function in man. Pharmacol Res Commun (1984) 0.79
Pituitary-gonadal function in heroin addicts. Neuropsychobiology (1977) 0.79
Role of testosterone in maintaining lean body mass and bone density in HIV-infected patients. Int J Impot Res (2003) 0.78
The control of the gonadotrophin releasing hormone pulse generator in relation to opioid and nutritional cues. Hum Reprod (1993) 0.78
Aromatization is not required for androgen induced changes in proopiomelanocortin gene expression in the hypothalamus. Brain Res Mol Brain Res (1994) 0.78
Mechanism of action of narcotics in the production of menstrual dysfunction in women. Fertil Steril (1975) 0.77
Methadone blocks dopamine-mediated release of gonadotropins in rat hypothalamus. Neuroendocrinology (1982) 0.76
Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch Intern Med (2005) 6.02
Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy. J Clin Oncol (2006) 3.09
Androgen levels in older men who have or who are at risk of acquiring HIV infection. Clin Infect Dis (2005) 2.55
Endogenous sex hormones and glucose tolerance status in postmenopausal women. J Clin Endocrinol Metab (2007) 2.29
Ambiguous genitalia with perineoscrotal hypospadias in 46,XY individuals: long-term medical, surgical, and psychosexual outcome. Pediatrics (2002) 2.26
Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy. Cancer (2006) 2.10
Sex-based differences in pain perception and treatment. Pain Med (2009) 1.82
46,XY intersex individuals: phenotypic and etiologic classification, knowledge of condition, and satisfaction with knowledge in adulthood. Pediatrics (2002) 1.76
The association of endogenous sex hormones, adiposity, and insulin resistance with incident diabetes in postmenopausal women. J Clin Endocrinol Metab (2009) 1.71
Long-term effects of androgen deprivation therapy in prostate cancer patients. Clin Endocrinol (Oxf) (2002) 1.64
Long-term corticosteroid replacement and bone mineral density in adult women with classical congenital adrenal hyperplasia. J Clin Endocrinol Metab (2005) 1.63
Degree of external genital malformation at birth in children with a disorder of sex development and subsequent caregiver distress. J Urol (2012) 1.45
Lack of an effect of high dose isoflavones in men with prostate cancer undergoing androgen deprivation therapy. J Urol (2009) 1.44
Endocrine effects of marijuana. J Clin Pharmacol (2002) 1.35
Reduced bone mineral density in human immunodeficiency virus-infected patients and its association with increased central adiposity and postload hyperglycemia. J Clin Endocrinol Metab (2004) 1.32
Endogenous postmenopausal hormones and serum lipids: the atherosclerosis risk in communities study. J Clin Endocrinol Metab (2004) 1.29
Developmental exposure to polychlorinated biphenyls interferes with experience-dependent dendritic plasticity and ryanodine receptor expression in weanling rats. Environ Health Perspect (2008) 1.27
Androgen deficiency, diabetes, and the metabolic syndrome in men. Curr Opin Endocrinol Diabetes Obes (2007) 1.26
Klinefelter syndrome: expanding the phenotype and identifying new research directions. Genet Med (2003) 1.21
Sex hormones, insulin resistance, and diabetes mellitus among men with or at risk for HIV infection. J Acquir Immune Defic Syndr (2011) 1.17
Association of endogenous sex hormones with diabetes and impaired fasting glucose in men: multi-ethnic study of atherosclerosis. Diabetes Care (2009) 1.14
Longitudinal increases in waist circumference are associated with HIV-serostatus, independent of antiretroviral therapy. AIDS (2007) 1.09
Male hypogonadism in systemic disease. Endocrinol Metab Clin North Am (2007) 1.09
Depressive symptoms, quality of life, and neuropsychological performance in HIV/AIDS: the impact of gender and injection drug use. J Neurovirol (2005) 1.08
Longitudinal anthropometric changes in HIV-infected and HIV-uninfected men. J Acquir Immune Defic Syndr (2006) 1.07
Changes in the incidence and predictors of wasting syndrome related to human immunodeficiency virus infection, 1987-1999. Am J Epidemiol (2002) 1.07
Cognitive outcome in adult women affected by congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Horm Res (2006) 1.04
Fat distribution and longitudinal anthropometric changes in HIV-infected men with and without clinical evidence of lipodystrophy and HIV-uninfected controls: a substudy of the Multicenter AIDS Cohort Study. AIDS Res Ther (2009) 0.98
New testosterone buccal system (Striant) delivers physiological testosterone levels: pharmacokinetics study in hypogonadal men. J Clin Endocrinol Metab (2004) 0.97
Age-related skeletal muscle decline is similar in HIV-infected and uninfected individuals. J Gerontol A Biol Sci Med Sci (2011) 0.96
Opiate drug use: a potential contributor to the endocrine and metabolic complications in human immunodeficiency virus disease. Clin Infect Dis (2003) 0.95
Topical testosterone supplementation for the treatment of male hypogonadism. Drugs (2012) 0.94
A model of delivering multi-disciplinary care to people with 46 XY DSD. J Pediatr Urol (2011) 0.93
The prevalence of low sex steroid hormone concentrations in men in the Third National Health and Nutrition Examination Survey (NHANES III). Clin Endocrinol (Oxf) (2011) 0.93
Pharmacokinetic and metabolic effects of American ginseng (Panax quinquefolius) in healthy volunteers receiving the HIV protease inhibitor indinavir. BMC Complement Altern Med (2008) 0.93
Gender role across development in adults with 46,XY disorders of sex development including perineoscrotal hypospadias and small phallus raised male or female. J Pediatr Endocrinol Metab (2008) 0.91
The effect of androgens on lipids. Curr Opin Endocrinol Diabetes Obes (2013) 0.90
Parenting characteristics of female caregivers of children affected by chronic endocrine conditions: a comparison between disorders of sex development and type 1 diabetes mellitus. J Pediatr Nurs (2010) 0.88
Primary caregivers of children affected by disorders of sex development: mental health and caregiver characteristics in the context of genital ambiguity and genitoplasty. Int J Pediatr Endocrinol (2010) 0.88
Body composition, gender, and illicit drug use in an urban cohort. Am J Drug Alcohol Abuse (2007) 0.87
Sex differences in body composition early in life. Gend Med (2009) 0.87
Lipodystrophy and inflammation predict later grip strength in HIV-infected men: the MACS Body Composition substudy. AIDS Res Hum Retroviruses (2013) 0.87
Differences in adjustment by child developmental stage among caregivers of children with disorders of sex development. Int J Pediatr Endocrinol (2011) 0.87
Transition from pediatric to adult care for adolescents and young adults with a disorder of sex development. J Pediatr Adolesc Gynecol (2012) 0.86
Relation between duration of androgen deprivation therapy and degree of insulin resistance in men with prostate cancer. Arch Intern Med (2007) 0.86
Prevalence of low bone mineral density in a low-income inner-city population. J Bone Miner Res (2011) 0.85
Effects of testosterone on body composition of the aging male. Mech Ageing Dev (2004) 0.85
An Evidence-Based Model of Multidisciplinary Care for Patients and Families Affected by Classical Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency. Int J Pediatr Endocrinol (2010) 0.85
Nebido: a long-acting injectable testosterone for the treatment of male hypogonadism. Expert Opin Pharmacother (2005) 0.83
Serum sex steroid hormones and frailty in older American men of the Third National Health and Nutrition Examination Survey (NHANES III). Aging Male (2012) 0.83
Handedness, functional cerebral hemispheric lateralization, and cognition in male-to-female transsexuals receiving cross-sex hormone treatment. Arch Sex Behav (2005) 0.83
Long acting testosterone undecanoate therapy in men with hypogonadism: results of a pharmacokinetic clinical study. J Urol (2008) 0.83
Clinicians' attitudes and usage of complementary and alternative integrative medicine: a survey at the Johns Hopkins Medical Institute. J Altern Complement Med (2007) 0.83
Early exposure to genistein exerts long-lasting effects on the endocrine and immune systems in rats. Mol Med (2002) 0.83
Hypothalamic-pituitary-gonadal function in men and women using heroin and cocaine, stratified by HIV status. Gend Med (2007) 0.83
Pharmacokinetics and safety of long-acting testosterone undecanoate injections in hypogonadal men: an 84-week phase III clinical trial. J Androl (2010) 0.82
Testosterone making an entry into the cardiometabolic world. Circulation (2007) 0.82
Lower adiponectin is associated with subclinical cardiovascular disease among HIV-infected men. AIDS (2014) 0.82
Morning free and total testosterone in HIV-infected men: implications for the assessment of hypogonadism. AIDS Res Ther (2014) 0.82
Gender role across development in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Pediatr Endocrinol Metab (2004) 0.82
Elevated HDL cholesterol levels are associated with osteoporosis in lung transplant candidates with chronic obstructive pulmonary disease. Respir Med (2010) 0.81
Differences in anxiety and depression between male and female caregivers of children with a disorder of sex development. J Pediatr Endocrinol Metab (2014) 0.81
Effect of methyl testosterone administration on plasma viscosity in postmenopausal women. Clin Endocrinol (Oxf) (2002) 0.81
Cortisol levels and depression in men and women using heroin and cocaine. Psychoneuroendocrinology (2005) 0.81
Effects of genistein in the maternal diet on reproductive development and spatial learning in male rats. Horm Behav (2010) 0.81
Current and future testosterone delivery systems for treatment of the hypogonadal male. Expert Opin Drug Deliv (2008) 0.80
Effects of simvastatin, an HMG-CoA reductase inhibitor, in patients with hypertriglyceridemia. Clin Cardiol (2003) 0.79
Association between sex steroid hormones and hematocrit in a nationally representative sample of men. J Androl (2012) 0.78
Clinical review: Controversies regarding transdermal androgen therapy in postmenopausal women. J Clin Endocrinol Metab (2006) 0.78
Different outcomes of hypospadias surgery between north america, europe and china: is patient age a factor? Nephrourol Mon (2012) 0.78
The challenges of randomized trials in integrative cancer care. Integr Cancer Ther (2004) 0.77
Nonsteroidal selective androgen receptor modulator Ostarine in cancer cachexia. Future Oncol (2009) 0.77
The effects of illicit drug use and HIV infection on sex hormone levels in women. Gynecol Endocrinol (2006) 0.77
Association of serum cholesterol and cholesterol-lowering drug use with serum sex steroid hormones in men in NHANES III. Cancer Causes Control (2010) 0.77
Evaluation of high-dose estrogen and high-dose estrogen plus methyltestosterone treatment on cognitive task performance in postmenopausal women. Horm Res (2002) 0.76
Working with adolescents and young adults to support transition. Endocr Dev (2014) 0.76
Fish oil supplementation in the treatment of cachexia in pancreatic cancer patients. Int J Gastrointest Cancer (2003) 0.76
Human sex differentiation and its abnormalities. Best Pract Res Clin Obstet Gynaecol (2003) 0.76
Omega-3 fatty acids for the treatment of cancer cachexia: issues in designing clinical trials of dietary supplements. J Altern Complement Med (2005) 0.76
Prostate screening in patients with 46,XY disorders of sex development--is it necessary? J Urol (2008) 0.76
New modalities of transdermal testosterone replacement. Treat Endocrinol (2003) 0.76
Medical and psychosexual outcome in women affected by complete gonadal dysgenesis. J Pediatr Endocrinol Metab (2006) 0.76
Longitudinal Changes Over 10 Years in Free Testosterone Among HIV-Infected and HIV-Uninfected Men. J Acquir Immune Defic Syndr (2016) 0.75
Osteoprotegerin, but Not Receptor Activator for Nuclear Factor-κB Ligand, is Associated With Subclinical Coronary Atherosclerosis in HIV-Infected Men. J Acquir Immune Defic Syndr (2015) 0.75
Sex determination, differentiation, and identity. N Engl J Med (2004) 0.75
Relationship between sex hormones and cognitive performance in men with substance use. Drug Alcohol Depend (2012) 0.75
Testosterone and Abnormal Glucose Metabolism in an Inner-City Cohort. J Mens Health (2012) 0.75
Normal sex differences in prenatal growth and abnormal prenatal growth retardation associated with 46,XY disorders of sex development are absent in newborns with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Biol Sex Differ (2011) 0.75
Point-counterpoint: using clinical trials for the evaluation of integrative cancer therapies. Integr Cancer Ther (2004) 0.75
Safety and adverse effects of androgens: how to counsel patients. Mayo Clin Proc (2004) 0.75
Streamlining the clinical research enterprise. J Investig Med (2002) 0.75
Is hypogonadism a risk factor for sexual dysfunction? J Androl (2003) 0.75